Insider Transactions Reported by 9 Insiders of Viking Therapeutics, Inc.

Symbol
VKTX on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

Viking Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Brian Lian President & CEO, Director $87,640,388 -$9,804,676 -10% 02 Jan 2026
Marianna Mancini Chief Operating Officer $14,351,561 -$2,236,370 -13% 02 Jan 2026
GREG ZANTE Chief Financial Officer $6,093,355 -$2,231,878 -27% 02 Jan 2026
MATTHEW W. FOEHR Director $5,030,271 -$561,694 -10% 02 Jan 2026
LAWSON MACARTNEY Director $1,901,989 02 Jan 2026
Charles A. Rowland Jr Director $1,233,511 -$2,134,278 -63% 02 Jan 2026
J. MATTHEW SINGLETON Director $470,706 02 Jan 2026
Sarah Kathryn Rouan Director $163,351 +$29,943 +22% 02 Jan 2026
Neil William Aubuchon Chief Commercial Officer $149,912 +$149,913 10 Mar 2026

Recent Insider Transactions by Companies or Individuals for Viking Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.